PF-08634404 (Pfizer) Global First Subject First Dose at First-in-Human Phase 1 Study

On February 17, 2026, the Department of New Experimental Therapeuti...

View More

ABBV-711 (AbbVie) Global First Subject First Dose at First-in-Human Phase 1 Study

On December 8, 2025, the Department of New Experimental Therapeutic...

View More

GSK5460025 (GlaxoSmithKline) Global First Subject First Dose at First-in-Human Phase...

On November 5, 2025, the Department of New Experimental Therapeutic...

View More

NEXT Oncology Expands to Japan in Joint Venture Partnership With Kansai Medical Univ...

View More

Expanding FIH Phase 1 Inpatient Wards for Reinforcing Early Phase Oncology Clinical ...

Expanding FIH Phase 1 inpatient wards for reinforcing early phase o...

View More

AbbVie ABBV-324 -First Administration of Investigational Cancer Drug in Asia (Global...

On July 8, 2025, the Department of New Experimental Therapeutics an...

View More